trending Market Intelligence /marketintelligence/en/news-insights/trending/ITNQdxeLpnTqGOnShvhVFQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

WuXi Biologics' 2018 profit up 73.6% YOY

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

WuXi Biologics' 2018 profit up 73.6% YOY

WuXi Biologics (Cayman) Inc.'s adjusted net profit for full year 2018 increased by 73.6% to 751.5 million Chinese yuan from 432.9 million yuan in 2017.

The China-based provider of biologics services said its adjusted EPS rose by 54.1% to 57 fens from 37 fens in the previous year.

The Hong Kong-listed company said its potential milestone payments will continue to boost its profit margin and improve profitability.

WuXi's revenue increased by 56.6% to 2.53 billion yuan for the year ended Dec. 31, 2018, compared to 1.62 billion yuan in 2017.

On a GAAP basis, the company reported a net profit of 630.5 million yuan, or 48 fen per share, which compares to 252.6 million, or 22 fen per share, in 2017.

As of March 15, US$1 was equivalent to 6.71 Chinese yuan.